Table 4 Prevalence of HPV 6, 11, 16 and 18 infections in CIN 1–3 lesions
From: Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women
Histologic Diagnosis/HPV Type(s) | n (%) |
|---|---|
CIN 1 | Â |
HPV 6 | 10 (5.2) |
HPV 6 and 16 | 1 (0.5) |
HPV 6, 16 and 18 | 1 (0.5) |
HPV 16 | 30 (15.6) |
HPV 16 and 18 | 1 (0.5) |
HPV 18 | 7 (3.6) |
Negative for HPV 6, 11, 16 and 18 | 142 (74.0) |
Total | 192 (100.0) |
CIN 2 | Â |
HPV 6 | 2 (5.6) |
HPV 6 and 16 | 1 (2.8) |
HPV 16 | 12 (33.3) |
HPV 18 | 3 (8.3) |
Negative for HPV 6, 11, 16 and 18 | 18 (50.0) |
Total | 36 (100.0) |
CIN 3 | Â |
HPV 6 | 1 (5.9) |
HPV 16 | 10 (58.8) |
HPV 16 and 18 | 1 (5.9) |
Negative for HPV 6, 11, 16 and 18 | 5 (29.4) |
Total | 17 (100.0) |